Quick answers
- What is Absorica LD?
- Absorica LD is a brand name of Isotretinoin, a prescription medicine. The FDA NDC Directory lists 4 Absorica LD products in 4 strengths and forms.
- Who makes Absorica LD?
- Sun Pharm holds the FDA application for Absorica LD (NDA211913, approved November 5, 2019).
- Is there a generic or store brand of Absorica LD?
- Other products of Isotretinoin are listed with the FDA, but none in exactly the same strength and form as a Absorica LD product.
- What do pharmacies pay for Absorica LD?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Absorica LD strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Absorica LD been recalled?
- FDA enforcement reports list 2 recalls of Absorica LD products; the newest started December 7, 2018. A recall usually concerns specific lots, not every product.
What Absorica LD is
Each Absorica LD product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Isotretinoin · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| isotretinoin 16 mg capsule (oral) | Absorica LD | None listed | DailyMed |
| isotretinoin 24 mg capsule (oral) | Absorica LD | None listed | DailyMed |
| isotretinoin 32 mg capsule (oral) | Absorica LD | None listed | DailyMed |
| isotretinoin 8 mg capsule (oral) | Absorica LD | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Isotretinoin →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA211913 | Sun Pharm | November 5, 2019 | 4 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| isotretinoin 16 mg capsule | Brand: Absorica LD | $38.41 per capsule |
| isotretinoin 24 mg capsule | Brand: Absorica LD | $42.23 per capsule |
| isotretinoin 32 mg capsule | Brand: Absorica LD | $42.42 per capsule |
NADAC list of November 4, 2026; these prices took effect between December 17, 2025 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Absorica LD
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Absorica LD products.
- Sun Pharmaceutical Industries, Inc.4 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 7, 2018 · Class III · Terminated · D-1207-2019
Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.
Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cran — Sun Pharmaceutical Industries, Inc.
-
June 26, 2015 · Class II · Terminated · D-1288-2015
Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.
Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31. — Ranbaxy Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.